Prescriptions to prevent cravings and withdrawal symptoms see growth, but remain a fraction of opioid prescription counts.

Bayer announced today initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha ...

While nations like South Africa and Egypt are making early strides in quantum research, Ghana has a unique opportunity to ...

Around 91.5% of patients reported meaningful reductions in tinnitus, outpacing data that granted Neuromod’s system FDA de ...

It is better for doctors and for the healthcare system when more people are sick and rely on medical interventions.